The Management of Drug-Influenced Gingival Enlargement

Primary Dental Journal
Noha Zoheir, Francis J Hughes

Abstract

<br/> Drug-influenced gingival enlargement (DIGE) is a reaction to specific medications, namely phenytoin, ciclosporin and calcium channel blockers. DIGE is encountered increasingly in clinical practice due to the widespread use of calcium channel blocker drugs particularly. Approaches to its management are discussed in this review.<br/> Methods: Narrative review of the literature and discussion of clinical implications.<br/> Findings: Management of DIGE involves nonsurgical treatment and may require surgical reduction of the overgrown gingival tissues. Management is complicated by the difficulties in achieving adequate plaque control, given the unfavourable contour of the enlarged gingival tissues, and the high frequency of recurrence of DIGE after surgical management. Replacing the drug involved can be very beneficial in selected cases, but the management of the underlying medical condition limits its application. The decision to replace a drug is not the responsibility of the dental practitioner, but the patient's physician may make it after consultation.<br/> Conclusions: Management of DIGE can be challenging and may require close co-operation between the dental practitioner and a hygienist, a periodontist and the patient's...Continue Reading

References

Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·T M HassellC G Cooper
Oct 1, 1992·Community Dentistry and Oral Epidemiology·J M ThomasonM D Rawlins
May 1, 1991·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·L FattoreJ M Doherty-Greenberg
May 25, 1991·British Dental Journal·R A Seymour
Apr 1, 1990·International Journal of Oral and Maxillofacial Surgery·T TagawaM Murata
Jul 1, 1985·Journal of Clinical Periodontology·R A SeymourD N Turnbull
Dec 1, 1984·Journal of Periodontology·T D Daley, G P Wysocki
Aug 1, 1994·Journal of Periodontology·A F HeftiC Stone
Jan 1, 1993·Journal of Clinical Periodontology·J M ThomasonN Rice
Jul 1, 1997·Journal of Periodontology·M G Jorgensen
Sep 2, 1998·Transplantation Proceedings·L BurrowsR Anand
Dec 22, 1999·Lasers in Surgery and Medicine·K GoharkhayW Sperr
Mar 7, 2000·Journal of Clinical Periodontology·J A JamesG J Linden
Jul 29, 2000·Journal of Clinical Periodontology·M P MajolaM H Laher
Aug 26, 2000·Journal of Clinical Periodontology·L MontebugnoliF Bernardi
Aug 10, 2001·Journal of Periodontology·M I UzelP C Trackman
Oct 9, 2001·European Journal of Clinical Investigation·L BrunetC Mendieta
Oct 22, 2005·International Journal of Paediatric Dentistry·G WrightM T Hosey
Jul 22, 2006·Journal of Clinical Periodontology·M MavrogiannisJ M Thomason
Dec 17, 2010·Journal of Clinical Periodontology·Arne S SchäferBruno G Loos
Oct 12, 2012·Journal of Indian Society of Periodontology·Vaibhavi Joshipura
Oct 25, 2014·British Dental Journal·P A Heasman, F J Hughes
Feb 15, 2015·Journal of Dental Research·P C Trackman, A Kantarci
Aug 1, 2015·Journal of Indian Society of Periodontology·Saumiya GopalAbhijeet Rajendra Shete
Jan 13, 2018·Contemporary Clinical Dentistry·Kehinde Adesola UmeizudikeBabawale T Bello
Jan 20, 2018·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Luana CamposFabiana Martins
Sep 11, 2018·Periodontology 2000·Francis J Hughes, P Mark Bartold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.